| Financial Year |
March 31 2023 |
| Monetary Funds |
2,124,576,281.30 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
111,833,079.01 |
| Accounts Receivable |
1,551,192,643.26 |
| Advances to Suppliers |
188,749,490.69 |
| Other Receivables |
52,744,602.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,831,197,814.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
164,924,600.37 |
| Total Current Assets |
6,036,142,790.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,561,955.29 |
| Investment Properties |
19,158,521.76 |
| Fixed Assetes |
1,220,702,522.19 |
| Under-construction Projects |
370,485,533.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
406,248,876.59 |
| R&D expenses |
54,123,400.63 |
| Goodwill |
278,124,783.91 |
| Long-Term Deferred and Prepaid Expenses |
25,069,903.38 |
| Deferred Income Tax Assets |
133,185,097.83 |
| Other Non-Current Assets |
171,110,417.00 |
| Sub-Total of Non-Current Assets |
2,756,166,475.05 |
| Total Assets |
8,792,309,265.81 |
| Short-Term Loans |
330,074,444.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
31,424,995.46 |
| Accounts Payable |
457,387,123.44 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
54,373,606.97 |
| Taxes Payable |
11,801,677.98 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,504,851.98 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,320,243.31 |
| Other Current Liabilities |
11,696,019.61 |
| Sub-Total of Current Liabilities |
1,314,846,532.94 |
| Long-term Loans |
32,504,057.74 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,070,271.10 |
| Deferred Income Tax Liabilities |
12,412,942.22 |
| Other Non-Current Liabilities |
22,000,000.00 |
| Sub-Total of Non-Current Liabilities |
271,508,592.67 |
| Total Liabilities |
1,586,355,125.61 |
| Paid-In Capital(Or Share Stock) |
3,285,181,622.00 |
| Capital Surplus |
1,757,120,896.35 |
| Surplus Reserve |
317,333,132.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,760,174,340.97 |
| Minority Stockholder's Interest |
51,439,772.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,154,514,367.81 |
| Owner's Equity（Stockholder's Equity） |
7,205,954,140.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,792,309,265.81 |
